Sciences Ltd. Roivant's Net Worth
Sciences Ltd. Roivant's net worth is estimated to be at least $214,768,525.07 as of 11/09/2024. CoreStreet's estimation of Sciences Ltd. Roivant's net worth is based on their sale of stock and current holding of stock.
Sciences Ltd. Roivant is Director at Immunovant Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,526,316 units of IMVT stock on 10/02/2023. Their biggest sale was on when they sold units of stock for $. They typically trade 2 times per year.
Total value of insider buys:
- $214,768,525.07
Total value of insider sells:
- $0.00
Most recent insider trade:
- Oct. 2, 2023
Sciences Ltd. Roivant's Insider Trading History
| Roivant Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 2, 2023 | Director | 1,526,316 | $38.00 | Buy | $58,000,008.00 |
Oct. 6, 2022 | Major Shareholder | 416,667 | $6.00 | Buy | $2,500,002.00 |
| Immunovant Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 2, 2023 | Director | 1,526,316 | $38.00 | Buy | $58,000,008.00 |
Oct. 6, 2022 | Major Shareholder | 416,667 | $6.00 | Buy | $2,500,002.00 |
Sept. 4, 2020 | Major Shareholder | 380,000 | $33.00 | Buy | $12,540,000.00 |
| Sio Gene Therapies Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 24, 2020 | Major Shareholder | 5,333,333 | $3.75 | Buy | $19,999,998.75 |
| Myovant Sciences Ltd | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 16, 2019 | Major Shareholder | 170,000 | $15.13 | Buy | $2,572,100.00 |
Dec. 4, 2019 | Major Shareholder | 75,000 | $17.06 | Buy | $1,279,500.00 |
Dec. 2, 2019 | Major Shareholder | 179,193 | $18.44 | Buy | $3,304,318.92 |
Nov. 25, 2019 | Major Shareholder | 3,500,000 | $15.00 | Buy | $52,500,000.00 |
Nov. 20, 2019 | Major Shareholder | 121,906 | $12.90 | Buy | $1,572,587.40 |